Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma
Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
5 Jun 2015
Comment: Eribulin extends overall survival for advanced liposarcoma and leiomyos...
Prof Gary Schwartz - Columbia University, New York, USA
1 Jun 2015
Eribulin extends overall survival for patients with advanced liposarcoma and lei...
Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
30 May 2015
ecancermedicalscience editor's choice for February 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
3 Mar 2015
New approaches and new partnership models for biomarker based clinical research
Dr Denis Lacombe, EORTC, Brussels, Belgium
6 Jan 2015
Aims and successes of the 2nd EurocanPlatform project translational research cou...
Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
6 Jan 2015
Epigenome deregulation in cancer
Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, Fran...
6 Jan 2015
Immunotherapy of cancer: recent progress and future challenges
Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
6 Jan 2015
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
6 Jan 2015
2nd EurocanPlatform translational research course is good for networking
Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
6 Jan 2015
Biobanking biological materials and linkage to clinical information
Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
6 Jan 2015
The role of health economics in cancer outcomes research
Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
6 Jan 2015
